Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-049452

Atara Biotherapeutics, Inc. · ATRA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Aug 15, 2017
Accepted (ET)
Aug 17, 2017 · 5:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604464

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Aug 15, 2017M1,548$0.00A108,922D
Common StockF1Aug 15, 2017M818$0.00A109,740D
Common StockAug 16, 2017S1,184$14.30D108,556D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF3,F4,F5—Aug 15, 2017M1,548D——Common Stock1,5483,097D
Restricted Stock UnitsF3,F6,F7—Aug 15, 2017M818D——Common Stock8182,179D

Explanation of responses